Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Strontium ranelate increases the formation of bone-like mineralized nodules in osteoblast cell cultures and leads to Sr incorporation into the intact nodules.

Querido W, Farina M.

Cell Tissue Res. 2013 Nov;354(2):573-80. doi: 10.1007/s00441-013-1669-8. Epub 2013 Jun 18.

PMID:
23774883
2.

Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells.

Barbara A, Delannoy P, Denis BG, Marie PJ.

Metabolism. 2004 Apr;53(4):532-7.

PMID:
15045704
3.

Strontium ranelate changes the composition and crystal structure of the biological bone-like apatite produced in osteoblast cell cultures.

Querido W, Campos AP, Martins Ferreira EH, San Gil RA, Rossi AM, Farina M.

Cell Tissue Res. 2014 Sep;357(3):793-801. doi: 10.1007/s00441-014-1901-1. Epub 2014 May 24. Erratum in: Cell Tissue Res. 2014 Sep;357(3):835.

PMID:
24859219
4.

Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.

Busse B, Jobke B, Hahn M, Priemel M, Niecke M, Seitz S, Zustin J, Semler J, Amling M.

Acta Biomater. 2010 Dec;6(12):4513-21. doi: 10.1016/j.actbio.2010.07.019. Epub 2010 Jul 21.

PMID:
20654744
5.

Strontium potently inhibits mineralisation in bone-forming primary rat osteoblast cultures and reduces numbers of osteoclasts in mouse marrow cultures.

Wornham DP, Hajjawi MO, Orriss IR, Arnett TR.

Osteoporos Int. 2014 Oct;25(10):2477-84. doi: 10.1007/s00198-014-2791-5. Epub 2014 Jul 22.

6.
7.

Effects of strontium on the physicochemical characteristics of hydroxyapatite.

Verberckmoes SC, Behets GJ, Oste L, Bervoets AR, Lamberts LV, Drakopoulos M, Somogyi A, Cool P, Dorriné W, De Broe ME, D'Haese PC.

Calcif Tissue Int. 2004 Nov;75(5):405-15. Epub 2004 Jul 30.

PMID:
15592797
8.

Strontium ranelate in osteoporosis.

Reginster JY.

Curr Pharm Des. 2002;8(21):1907-16. Review.

PMID:
12171530
9.

Strontium ranelate increases osteoblast activity.

Almeida MM, Nani EP, Teixeira LN, Peruzzo DC, Joly JC, Napimoga MH, Martinez EF.

Tissue Cell. 2016 Jun;48(3):183-8. doi: 10.1016/j.tice.2016.03.009. Epub 2016 Apr 16.

PMID:
27157549
10.

Dose-dependent effects of strontium on osteoblast function and mineralization.

Verberckmoes SC, De Broe ME, D'Haese PC.

Kidney Int. 2003 Aug;64(2):534-43.

11.

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response.

Atkins GJ, Welldon KJ, Halbout P, Findlay DM.

Osteoporos Int. 2009 Apr;20(4):653-64. doi: 10.1007/s00198-008-0728-6. Epub 2008 Sep 2.

PMID:
18763010
12.

Strontium is incorporated in different levels into bones and teeth of rats treated with strontium ranelate.

Oliveira JP, Querido W, Caldas RJ, Campos AP, Abraçado LG, Farina M.

Calcif Tissue Int. 2012 Sep;91(3):186-95. doi: 10.1007/s00223-012-9625-2. Epub 2012 Jul 18.

PMID:
22806682
13.

Osteoblast response to titanium surfaces coated with strontium ranelate-loaded chitosan film.

Tian A, Zhai JJ, Peng Y, Zhang L, Teng MH, Liao J, Sun X, Liang X.

Int J Oral Maxillofac Implants. 2014 Nov-Dec;29(6):1446-53. doi: 10.11607/jomi.3806.

PMID:
25397808
14.

The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization.

Takaoka S, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T.

Horm Metab Res. 2010 Aug;42(9):627-31. doi: 10.1055/s-0030-1255091. Epub 2010 Jun 17.

PMID:
20560105
15.

Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.

Fernández JM, Molinuevo MS, Sedlinsky C, Schurman L, Cortizo AM, McCarthy AD.

Eur J Pharmacol. 2013 Apr 15;706(1-3):41-7. doi: 10.1016/j.ejphar.2013.02.042. Epub 2013 Mar 13.

PMID:
23499695
16.

Osteoblast-mediated mineral deposition in culture is dependent on surface microtopography.

Boyan BD, Bonewald LF, Paschalis EP, Lohmann CH, Rosser J, Cochran DL, Dean DD, Schwartz Z, Boskey AL.

Calcif Tissue Int. 2002 Dec;71(6):519-29. Epub 2002 Sep 18.

PMID:
12232675
17.

Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.

Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R.

J Bone Miner Res. 2004 Dec;19(12):2012-20. Epub 2004 Sep 13. Erratum in: J Bone Miner Res. 2005 Mar;20(3):548.

18.

Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.

Tat SK, Pelletier JP, Mineau F, Caron J, Martel-Pelletier J.

Bone. 2011 Sep;49(3):559-67. doi: 10.1016/j.bone.2011.06.005. Epub 2011 Jun 12.

PMID:
21700005
19.

Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride.

Pemmer B, Hofstaetter JG, Meirer F, Smolek S, Wobrauschek P, Simon R, Fuchs RK, Allen MR, Condon KW, Reinwald S, Phipps RJ, Burr DB, Paschalis EP, Klaushofer K, Streli C, Roschger P.

J Synchrotron Radiat. 2011 Nov;18(Pt 6):835-41. doi: 10.1107/S090904951103038X. Epub 2011 Sep 15.

PMID:
21997907
20.

Ultrastructural and mineral phase characterization of the bone-like matrix assembled in F-OST osteoblast cultures.

Querido W, Abraçado LG, Rossi AL, Campos AP, Rossi AM, San Gil RA, Borojevic R, Balduino A, Farina M.

Calcif Tissue Int. 2011 Nov;89(5):358-71. doi: 10.1007/s00223-011-9526-9. Epub 2011 Sep 7.

PMID:
21901516

Supplemental Content

Support Center